Novogen Ltd (NASDAQ:NVGN)

5.61
Delayed Data
As of May 29
 -0.06 / -1.06%
Today’s Change
1.51
Today|||52-Week Range
9.50
+169.71%
Year-to-Date

Today’s Trading

Previous close5.67
Today’s open5.74
Day’s range5.50 - 5.82
Volume168,312
Average volume (3 months)1,268,608
Market cap$37.8M
Dividend yield--
Data as of 3:59pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+18.03%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book31.23

Competitors

 Today’s
change
Today’s
% change
ACURAcura Pharmaceutical...0.000.00%
PTNPalatin Technologies...-0.01-0.72%
ACSTAcasti Pharma Inc-0.00-0.21%
GNVCGenVec Inc+0.01+0.43%
Data as of 3:59pm ET, 05/29/2015

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Graham Edmund Kelly
COO, Head-Administration &
Finance
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers